FDA Approves First Over-the-Counter Naloxone Nasal Spray
http://www.fda.gov/news-events/press-announcements/fda-approves-first-over-counter-naloxone-nasal-spray
Do you know of programs or organizations working in the prevention, control or elimination of #malaria? 👩🏾⚕️
They can be Malaria Champions of the Americas.
Learn more about how to apply: 📋
paho.org/en/malaria-cha… https://t.co/BM197eAi9v
FDA Roundup: March 28, 2023
http://www.fda.gov/news-events/press-announcements/fda-roundup-march-28-2023
❇️ The study, What is the NCD service capacity and disruptions due to COVID-19? Results from the WHO non-communicable disease country capacity survey in the Americas region, was published last month in the @BMJ_Open: bmjopen.bmj.com/content/13/3/e…
Extensive disruptions in the diagnosis and management of non-communicable diseases (NCDs) in the Americas during the COVID-19 pandemic had a “significant adverse impact on the region” warns a new study from PAHO.
ℹ️ Read more 👇🏽
paho.org/en/news/27-3-2… https://t.co/7RBgHt26VJ
FDA Outlines Immediate National Strategy to Further Increase the Resiliency of the U.S. Infant Formula Market
http://www.fda.gov/news-events/press-announcements/fda-outlines-immediate-national-strategy-further-increase-resiliency-us-infant-formula-market
🧬 Science in 5: Salt in our diet
What happens when we consume too much salt? And how can we reduce it in our diet? https://t.co/fNcRMIqFH2
Although global efforts 🌎 in the fight to end TB have saved 74 million lives since 2000, the pace of progress is slow. We need to increase actions and investments to end TB. #EndTB
🧑🏿🤝🧑🏿🧑🏻🤝🧑🏻 We must fight TB-related stigma and discrimination to prevent and control the disease. We must empower our communities and provide respectful, stigma-free care. Yes! We can end TB! #EndTB
